Clinical Trials Browser

Interventional × Refractory Solid Tumors × Temozolomide × Clear all

NCT06006273 2025-11-10

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Refractory Solid Tumors